Discovery and characterization of prolactin neutralizing monoclonal antibodies for the treatment of female-prevalent pain disorders

Maciuba, S; Bowden, GD; Stratton, HJ; Wisniewski, K; Schteingart, CD; Almagro, JC; Valadon, P; Lowitz, J; Glaser, SM; Lee, G; Dolatyari, M; Navratilova, E; Porreca, F; Rivière, PJM

Rivière, PJM (通讯作者),Peptide Log, San Diego, CA 92121 USA.

MABS, 2023; 15 (1):

Abstract

Prolactin (PRL) has recently been demonstrated to elicit female-selective nociceptor sensitization and increase pain-like behaviors in female animals.......

Full Text Link